Skip to main content

Table 2 Characteristics of study patients

From: Positive change in asthma control using therapeutic patient education in severe uncontrolled asthma: a one-year prospective study

Characteristics Total (n = 40)
Age (y) 50.3 ± 11.3
Gender (female/male) 25/15
Body mass index (kg/m2) 24.1 ± 4.4
Smoking status (never/ex), n 40/0
Atopy, n (%) 30 (75.0 %)
Duration of asthma (y) 10.5 (5.0-19.5)
Combine with rhinitis 28 (70.0 %)
Combine with atopic dermatitis 11 (27.5 %)
Combine with conjunctivitis 16 (40.0 %)
Dose of inhaled corticosteroids (ug/d) 1000(1000–2000)
Budesonide/formoterol, n (%) 24(60 %)
Fluticasone/salmeterol, n (%) 16(40 %)
Montelukast Sodiuma, n (%) 28(70 %)
Eos in blood(x103/uL) 0.27 ± 0.20
  1. aDrugs used in combination. Eos eosinophils